-- BHP, Gunns, Healthscope, Linc, Intoll, Rio, Nufarm: Australia, N.Z. Stocks
-- Shani Raja
-- 2010-07-15T06:19:12Z
-- http://www.bloomberg.com/news/2010-07-15/bhp-gunns-healthscope-linc-nufarm-rio-santos-australia-n-z-stocks.html

          
          
             Australia’s  S&P/ASX 200 Index  fell
0.4 percent to 4,442.60 at the close of trading in Sydney. New
Zealand’s  NZX 50 Index  declined 0.8 percent to 3,002.32 in
Wellington.  
 The following were among the most active shares in the
market today. Stock symbols are in parentheses after company
names.  
 Mining shares: Copper for three-month delivery dropped as
much as 1.8 percent to $6,603 a metric ton on the London Metal
Exchange before trading at $6,684 at 10:29 a.m. in Shanghai.  
 BHP Billiton  (BHP AU), the world’s largest mining company,
fell 0.7 percent to A$38.13.  
 Rio Tinto Group  (RIO AU), the world’s third-largest mining
company, decreased 1.1 percent to A$66.61.  
 Oil companies: Crude oil for August delivery dropped as
much as 0.7 percent to $76.50 a barrel on the New York
Mercantile Exchange. It was at $76.84 at 12:58 p.m. Singapore
time.  
 Woodside Petroleum Ltd.  (WPL AU), Australia’s second-
largest oil and gas producer, dropped 0.4 percent to A$42.85.
Rival  Santos Ltd.  (STO AU) declined 0.9 percent to A$13.77.  
 Gold producers: Gold for immediate delivery climbed 0.4
percent to $1,212.70 an ounce at 10:51 a.m. in Singapore.  
 Newcrest Mining Ltd.  (NCM AU), Australia’s biggest gold
producer, slipped 0.7 percent to A$35.02.  
 APA Group  (APA AU) rose 1.9 percent to A$3.77. The company,
whose pipelines carry more than half Australia’s natural gas,
raised A$300 million ($265 million) from 10-year bonds to
refinance maturing debt and reduce interest costs.  
 CSL Ltd.  (CSL AU), the world’s second-biggest maker of
medical treatments derived from blood, declined 2.8 percent to
A$32.80 after German rival Biotest AG cut its full-year earnings
forecast because of lower prices.  
 Gunns Ltd . (GNS AU) dropped 1.5 percent to 64.5 Australian
cents. Australia’s largest woodchip exporter was downgraded to
“neutral” from “buy” at UBS AG by equity analyst  Lachlan Parker .  
 Healthscope Ltd.  (HSP AU) fell 0.9 percent to A$5.41.
Carlyle Group, Blackstone Group and TPG Inc. remain in talks to
purchase Australia’s second-largest hospital operator, the Wall
Street Journal reported, citing an unidentified person familiar
with the situation. The Australian Financial Review said today
Carlyle may exit the group because of a disagreement over
pricing.  
 Intoll Group  (ITO AU) gained 30 percent to A$1.45. Canada
Pension Plan Investment Board offered A$3.47 billion ($3.1
billion) for Macquarie Group Ltd.-backed Intoll in its second
attempt to buy an Australian toll-road operator in eight months.  
 Nufarm Ltd.  (NUF AU) plunged 28 percent to A$3.75.
Australia’s largest supplier of farm chemicals cut its full-year
profit forecast and said it won’t achieve one of its loan
conditions. Nufarm also had its stock rating lowered at Credit
Suisse Group AG, Royal Bank of Scotland Group Plc and UBS AG.  
 Sigma Pharmaceuticals Ltd.  (SIP AU) fell 2.1 percent to
47.5 Australian cents. The target of a takeover by Aspen
Pharmacare Holdings Ltd., Africa’s biggest drugmaker, Melbourne-
based Sigma cut its full-year profit forecast by as much as 46
percent, citing competition in the generic-drug business.  
 To contact the reporters for this story:
 Lisa Pham  in Sydney at 
 lpham14@bloomberg.net .
 Shani Raja  in Sydney at 
 sraja4@bloomberg.net .  
          
          


  


        